3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
32
Multiple Myeloma
27
Breast Neoplasms
25
Carcinoma, Non-Small-Cell Lung
24
Leukemia, Myeloid, Acute
23
Lymphoma
20
Melanoma
16
Lymphoma, Non-Hodgkin
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Colorectal Neoplasms
14
Ovarian Neoplasms
13
Lung Neoplasms
12
Wilms Tumor
11
Neoplasm Metastasis
11
Myelodysplastic Syndromes
11
Hodgkin Disease
11
Carcinoma, Renal Cell
10
Squamous Cell Carcinoma of Head and Neck
9
Sarcoma
9
Fallopian Tube Neoplasms
9
Burkitt Lymphoma
9
Rhabdomyosarcoma
8
Rhabdoid Tumor
8
Neoplasms
8
Leukemia
8
Hepatoblastoma
8
Glioma
8
Colonic Neoplasms
8
Sarcoma, Ewing
7
Osteosarcoma
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Cachexia
×
30 days
×
Clear all
NCT05546476
2026-06-03
PROACC-1
Pfizer
Phase 2
Completed
187 enrolled
24 charts